^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    trastuzumab conjugate (BI-CON-02)

    i
    Other names: BI-CON-02
    Associations
    News
    Trials
    Company:
    ChemRar
    Drug class:
    HER2-targeted antibody-drug conjugate
    Related drugs:
    Associations
    News
    Trials